BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33844466)

  • 21. Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain.
    Nagalski A; Irimia M; Szewczyk L; Ferran JL; Misztal K; Kuznicki J; Wisniewska MB
    Brain Struct Funct; 2013 Nov; 218(6):1531-49. PubMed ID: 23152144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
    Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M
    PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
    Wang M; Zhang C
    PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.
    Du X; Liu H; Yang C; Shi X; Cao L; Zhao X; Miao Y; Zhu H; Wang L; Xu W; Li J; Fan L
    Leuk Res; 2021 Nov; 110():106706. PubMed ID: 34563944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
    Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
    PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.
    Spaulding C; Reschly EJ; Zagort DE; Yashiro-Ohtani Y; Beverly LJ; Capobianco A; Pear WS; Kee BL
    Blood; 2007 Oct; 110(7):2650-8. PubMed ID: 17585052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
    Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
    Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran.
    Mohammadi M; Amirmahani F; Goharrizi KJ; Pakzad R; Dolat H
    Mol Biol Rep; 2019 Jun; 46(3):2679-2684. PubMed ID: 31037549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.
    Tiemessen MM; Baert MR; Schonewille T; Brugman MH; Famili F; Salvatori DC; Meijerink JP; Ozbek U; Clevers H; van Dongen JJ; Staal FJ
    PLoS Biol; 2012; 10(11):e1001430. PubMed ID: 23185135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
    Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
    Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.
    Santiago L; Daniels G; Wang D; Deng FM; Lee P
    Am J Cancer Res; 2017; 7(6):1389-1406. PubMed ID: 28670499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
    Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
    Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.
    Gutierrez A; Tschumper RC; Wu X; Shanafelt TD; Eckel-Passow J; Huddleston PM; Slager SL; Kay NE; Jelinek DF
    Blood; 2010 Oct; 116(16):2975-83. PubMed ID: 20595513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.